Literature DB >> 133083

Adjuvant and mitogenic properties of a supernatant fraction of sonically treated Myobacterium bovis (BCG).

L A Baker, T Sharpton, P Minden, P A Campbell.   

Abstract

A water-soluble, oil-free supernatant fraction of sonically treated BCG (BCG-SS) was shown to be an immunological adjuvant and a mitogen. When BCG-SS and sheep erythrocytes (SRBC) were injected intravenously into mice, the plaque-forming cell (PFC) response was 10 times greater than that induced by injection of SRBC alone. Circulating antibody responses to SRBC and to bovine serum albumin were also enhanced by BCG-SS. The in vitro enhancement of PFC and circulating antibody responses did not require mineral oil or exogenous lipids. In vitro PFC responses by normal mouse spleen cells were also greatly increased in the presence of BCG-SS. Anti-theta serum-treated spleen cells from mice that had been lethally irradiated and reconstituted with normal bone marrow cells also gave a higher PFC response to SRBC in the presence of BCG-SS. This suggests that BCG-SS can stimulate B lymphocytes to develop an immune response when T lymphocytes are severely depleted or absent. BCG-SS also stimulated the uptake of 125IUdR by normal spleen cell cultures, indicating that it is a mitogen.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 133083      PMCID: PMC420847          DOI: 10.1128/iai.14.1.83-87.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Some variable controls for accurate heterologous anti-immunoglobulin (HAI) tests.

Authors:  P Minden; R S Farr; J Trembath
Journal:  Immunochemistry       Date:  1975-07

2.  Activation of lymphoid cells by BCG in vitro.

Authors:  M B Mokyr; M S Mitchell
Journal:  Cell Immunol       Date:  1975-02       Impact factor: 4.868

3.  Water-soluble and lipid-free fraction from BCG with adjuvant and antitumour activity.

Authors:  I J Hiu
Journal:  Nat New Biol       Date:  1972-08-23

4.  Protection against guinea pig hepatomas by pretreatment with subcelluar fractions of Mycobacterium bovis (BCG).

Authors:  P Minden; M Wainberg; D W Weiss
Journal:  J Natl Cancer Inst       Date:  1974-05       Impact factor: 13.506

5.  Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma.

Authors:  T J Meyer; E E Ribi; I Azuma; B Zbar
Journal:  J Natl Cancer Inst       Date:  1974-01       Impact factor: 13.506

6.  Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets.

Authors:  B Zbar; H J Rapp; E E Ribi
Journal:  J Natl Cancer Inst       Date:  1972-03       Impact factor: 13.506

7.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

8.  Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.

Authors:  P Minden; J K McClatchy; M Wainberg; D W Weiss
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

9.  Requirement for bone marrow-derived cells in resistance to Listeria.

Authors:  P A Campbell; B L Martens; H R Cooper; J K McClatchy
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

10.  Prevention of tumor growth after intradermal injection of BCG extracts: a comparison of results in strain-2 guinea pigs from the National Institutes of Health and from the National Jewish Hospital and Research Center.

Authors:  B Zbar; P Minden; J K McClatchy; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1976-02       Impact factor: 13.506

View more
  4 in total

1.  Immunological method to differentiate between antigens of tubercle bacilli, other mycobacterial species, and non-acid-fast bacteria.

Authors:  H R Ferguson; J K McClatchy; T R Sharpton; P Minden
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

2.  Mechanism of adjuvant activity of dental plaque: in vitro activation of residual helper T-cell precursors in T-cell-deficient murine spleen cell cultures.

Authors:  P Chen; J J Farrar; J J Oppenheim; S E Mergenhagen
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

3.  Immunological evaluation of a component isolated from Mycobacterium bovis BCG with a monoclonal antibody to M. bovis BCG.

Authors:  P Minden; P J Kelleher; J H Freed; L D Nielsen; P J Brennan; L McPheron; J K McClatchy
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

4.  A chemically synthesized peptide which elicits humoral and cellular immune responses to mycobacterial antigens.

Authors:  P Minden; R A Houghten; J R Spear; T M Shinnick
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.